{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T19:14:05Z","timestamp":1783710845292,"version":"3.55.0"},"reference-count":43,"publisher":"Xia & He Publishing","issue":"000","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,11]]},"DOI":"10.14218\/jcth.2021.00008","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T21:06:04Z","timestamp":1615410364000},"page":"000-000","source":"Crossref","is-referenced-by-count":13,"title":["Characteristics and Inpatient Outcomes of Primary Biliary Cholangitis and Autoimmune Hepatitis Overlap Syndrome"],"prefix":"10.14218","volume":"000","author":[{"given":"Yi","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-Hong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Pyrsopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5334","published-online":{"date-parts":[[2021,3,11]]},"reference":[{"key":"key20210310210547_JCTH-D-21-00008-b1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.path.2018.02.010","article-title":"Primary biliary cholangitis and autoimmune hepatitis","volume":"11","author":"Gonzalez","year":"2018","journal-title":"Surg Pathol Clin"},{"key":"key20210310210547_JCTH-D-21-00008-b2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/hep.510280210","article-title":"Frequency and nature of the variant syndromes of autoimmune liver disease","volume":"28","author":"Czaja","year":"1998","journal-title":"Hepatology"},{"key":"key20210310210547_JCTH-D-21-00008-b3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/hep.21229","article-title":"Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis","volume":"44","author":"Poupon","year":"2006","journal-title":"Hepatology"},{"key":"key20210310210547_JCTH-D-21-00008-b4","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cgh.2011.03.019","article-title":"Prevalence of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome","volume":"9","author":"Bonder","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20210310210547_JCTH-D-21-00008-b5","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J Hepatol"},{"key":"key20210310210547_JCTH-D-21-00008-b6","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.cgh.2015.08.012","article-title":"Autoimmune hepatitis and overlap syndromes: Diagnosis and management","volume":"13","author":"Vierling","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20210310210547_JCTH-D-21-00008-b7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3350\/cmh.2015.21.2.150","article-title":"Retrospective analysis of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome in Korea: characteristics, treatments, and outcomes","volume":"21","author":"Park","year":"2015","journal-title":"Clin Mol Hepatol"},{"key":"key20210310210547_JCTH-D-21-00008-b8","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1572-0241.2007.01136.x","article-title":"Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes","volume":"102","author":"Silveira","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"key20210310210547_JCTH-D-21-00008-b9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12016-015-8516-5","article-title":"The natural history and prognosis of primary biliary cirrhosis with clinical features of autoimmune hepatitis","volume":"50","author":"Yang","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"key20210310210547_JCTH-D-21-00008-b10","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/MEG.0b013e328350f95b","article-title":"Autoimmune hepatitis\/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases","volume":"24","author":"Efe","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key20210310210547_JCTH-D-21-00008-b11","unstructured":"Agency for Healthcare Research and Quality. HCUP NIS database documentation. Available from: https:\/\/www.hcup-us.ahrq.gov\/db\/nation\/nis\/nisdbdocumentation.jsp"},{"key":"key20210310210547_JCTH-D-21-00008-b12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/ajg.2017.456","article-title":"Hospitalizations for autoimmune hepatitis disproportionately affect black and Latino Americans","volume":"113","author":"Wen","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"key20210310210547_JCTH-D-21-00008-b13","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/hep4.1314","article-title":"Burden of primary biliary cholangitis among inpatient population in the United States","volume":"3","author":"Shahab","year":"2019","journal-title":"Hepatol Commun"},{"key":"key20210310210547_JCTH-D-21-00008-b14","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/MLR.0000000000000735","article-title":"Identifying increased risk of readmission and in-hospital mortality using hospital administrative data: The AHRQ elixhauser comorbidity index","volume":"55","author":"Moore","year":"2017","journal-title":"Med Care"},{"key":"key20210310210547_JCTH-D-21-00008-b15","first-page":"381","article-title":"Evidence for spontaneous immunosuppression in autoimmune hepatitis","volume":"22","author":"Lohse","year":"1995","journal-title":"Hepatology"},{"key":"key20210310210547_JCTH-D-21-00008-b16","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/hep.27884","article-title":"In autoimmune hepatitis type 1 or the autoimmune hepatitis-sclerosing cholangitis variant defective regulatory T-cell responsiveness to IL-2 results in low IL-10 production and impaired suppression","volume":"62","author":"Liberal","year":"2015","journal-title":"Hepatology"},{"key":"key20210310210547_JCTH-D-21-00008-b17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1055\/s-0034-1383729","article-title":"Breach of tolerance: primary biliary cirrhosis","volume":"34","author":"Wang","year":"2014","journal-title":"Semin Liver Dis"},{"key":"key20210310210547_JCTH-D-21-00008-b18","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.autrev.2016.07.003","article-title":"Novel therapeutics for primary biliary cholangitis: Toward a disease-stage-based approach","volume":"15","author":"Mousa","year":"2016","journal-title":"Autoimmun Rev"},{"key":"key20210310210547_JCTH-D-21-00008-b19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11901-017-0345-y","article-title":"Why doesn\u2019t primary biliary cholangitis respond to immunosuppressive medications?","volume":"16","author":"Molinaro","year":"2017","journal-title":"Curr Hepatol Rep"},{"key":"key20210310210547_JCTH-D-21-00008-b20","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ajg.2009.616","article-title":"Autoimmune hepatitis-PBC overlap syndrome: a simplified scoring system may assist in the diagnosis","volume":"105","author":"Neuhauser","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"key20210310210547_JCTH-D-21-00008-b21","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S1089-3261(03)00097-7","article-title":"Management of osteoporosis, fat-soluble vitamin deficiencies, and hyperlipidemia in primary biliary cirrhosis","volume":"7","author":"Levy","year":"2003","journal-title":"Clin Liver Dis"},{"key":"key20210310210547_JCTH-D-21-00008-b22","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/hep.1840050522","article-title":"Pathogenesis of steatorrhea in primary biliary cirrhosis","volume":"5","author":"Lanspa","year":"1985","journal-title":"Hepatology"},{"key":"key20210310210547_JCTH-D-21-00008-b23","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3748\/wjg.v9.i4.878","article-title":"Primary biliary cirrhosis and ulcerative colitis: a case report and review of literature","volume":"9","author":"Xiao","year":"2003","journal-title":"World J Gastroenterol"},{"key":"key20210310210547_JCTH-D-21-00008-b24","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1053\/gast.2000.9366","article-title":"\u201cAtypical p-ANCA\u201d in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines","volume":"119","author":"Terjung","year":"2000","journal-title":"Gastroenterology"},{"key":"key20210310210547_JCTH-D-21-00008-b25","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/jhg.2015.59","article-title":"Disease susceptibility genes shared by primary biliary cirrhosis and Crohn\u2019s disease in the Japanese population","volume":"60","author":"Aiba","year":"2015","journal-title":"J Hum Genet"},{"key":"key20210310210547_JCTH-D-21-00008-b26","doi-asserted-by":"crossref","first-page":"2376231","DOI":"10.1155\/2017\/2376231","article-title":"Extrahepatic autoimmune diseases in patients with autoimmune liver diseases: A phenomenon neglected by gastroenterologists","volume":"2017","author":"Guo","year":"2017","journal-title":"Gastroenterol Res Pract"},{"key":"key20210310210547_JCTH-D-21-00008-b27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2018.10.014","article-title":"Extrahepatic autoimmunity in autoimmune liver disease","volume":"59","author":"Floreani","year":"2019","journal-title":"Eur J Intern Med"},{"key":"key20210310210547_JCTH-D-21-00008-b28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.semarthrit.2005.09.002","article-title":"Reshaping the mosaic of autoimmunity","volume":"35","author":"Amital","year":"2006","journal-title":"Semin Arthritis Rheum"},{"key":"key20210310210547_JCTH-D-21-00008-b29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaut.2011.11.005","article-title":"Primary biliary cirrhosis and Sj\u00f6gren\u2019s syndrome: autoimmune epithelitis","volume":"39","author":"Selmi","year":"2012","journal-title":"J Autoimmun"},{"key":"key20210310210547_JCTH-D-21-00008-b30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1440-1827.2005.01790.x","article-title":"Autoimmune hepatitis in primary Sjogren\u2019s syndrome: pathological study of the livers and labial salivary glands in 17 patients with primary Sjogren\u2019s syndrome","volume":"55","author":"Matsumoto","year":"2005","journal-title":"Pathol Int"},{"key":"key20210310210547_JCTH-D-21-00008-b31","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/1751-2980.12791","article-title":"CTHRC1 expression in primary biliary cholangitis","volume":"20","author":"Li","year":"2019","journal-title":"J Dig Dis"},{"key":"key20210310210547_JCTH-D-21-00008-b32","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/MEG.0b013e328326cab6","article-title":"Hepatic stellate cell activation and hepatic fibrosis in children with type 1 autoimmune hepatitis: an immunohistochemical study of paired liver biopsies before treatment and after clinical remission","volume":"22","author":"Maia","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key20210310210547_JCTH-D-21-00008-b33","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/hep.23405","article-title":"Portal fibroblasts: Underappreciated mediators of biliary fibrosis","volume":"51","author":"Dranoff","year":"2010","journal-title":"Hepatology"},{"key":"key20210310210547_JCTH-D-21-00008-b34","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1053\/j.gastro.2005.01.007","article-title":"Bile acids induce hepatic stellate cell proliferation via activation of the epidermal growth factor receptor","volume":"128","author":"Svegliati-Baroni","year":"2005","journal-title":"Gastroenterology"},{"key":"key20210310210547_JCTH-D-21-00008-b35","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/MOG.0b013e328324f87e","article-title":"Farnesoid X receptor agonists in biliary tract disease","volume":"25","author":"Fiorucci","year":"2009","journal-title":"Curr Opin Gastroenterol"},{"key":"key20210310210547_JCTH-D-21-00008-b36","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/hep.24526","article-title":"Fine phenotypic and functional characterization of effector cluster of differentiation 8 positive T cells in human patients with primary biliary cirrhosis","volume":"54","author":"Tsuda","year":"2011","journal-title":"Hepatology"},{"key":"key20210310210547_JCTH-D-21-00008-b37","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.autrev.2005.01.005","article-title":"T cell immunity in autoimmune hepatitis","volume":"4","author":"Ichiki","year":"2005","journal-title":"Autoimmun Rev"},{"key":"key20210310210547_JCTH-D-21-00008-b38","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3109\/00365521.2014.974203","article-title":"Nitric oxide is a potential mediator of hepatic inflammation and fibrogenesis in autoimmune hepatitis","volume":"50","author":"Beyazit","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"key20210310210547_JCTH-D-21-00008-b39","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1572-0241.2001.03470.x","article-title":"Evidence of an increased nitric oxide production in primary biliary cirrhosis","volume":"96","author":"Battista","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"key20210310210547_JCTH-D-21-00008-b40","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.bbadis.2017.07.026","article-title":"Pathogenesis of biliary fibrosis","volume":"1864","author":"Pinzani","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"key20210310210547_JCTH-D-21-00008-b41","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bbadis.2004.01.005","article-title":"Oxidant stress in type I autoimmune hepatitis: the link between necroinflammation and fibrogenesis?","volume":"1689","author":"Pemberton","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"key20210310210547_JCTH-D-21-00008-b42","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00029330-200602010-00013","article-title":"Clinical features of the overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis: retrospective study","volume":"119","author":"Wu","year":"2006","journal-title":"Chin Med J (Engl)"},{"key":"key20210310210547_JCTH-D-21-00008-b43","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jhep.2005.10.017","article-title":"Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome","volume":"44","author":"Chazouill\u00e8res","year":"2006","journal-title":"J Hepatol"}],"container-title":["Journal of Clinical and Translational Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.xiahepublishing.com\/2310-8819\/JCTH-2021-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:19:43Z","timestamp":1783707583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.xiahepublishing.com\/2310-8819\/JCTH-2021-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,11]]},"references-count":43,"journal-issue":{"issue":"000","published-online":{"date-parts":[[2021,3,11]]},"published-print":{"date-parts":[[2021,3,11]]}},"alternative-id":["10.14218\/JCTH.2021.00008"],"URL":"https:\/\/doi.org\/10.14218\/jcth.2021.00008","relation":{},"ISSN":["2225-0719","2310-8819"],"issn-type":[{"value":"2225-0719","type":"print"},{"value":"2310-8819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,11]]}}}